Hematopoietic Cell Transplantation Donor-Derived Memory-Like NK Cells Functionally Persist after Transfer into Patients with Leukemia

Reduced-intensity conditioning for HLA-haploidentical hematopoietic cell transplantation was augmented with same-donor memory-like natural killer (NK) cells on day +7 and 3 weeks of N-803 to treat patients with relapsed/refractory AML in a clinical trial.